NCT01229631

Brief Summary

The objective of this study is to determine whether enhanced micronutrient intake in the form of fruit, vegetable and berry juice powder (FVB) concentrate, improves clinical outcomes in chronic periodontitis patients prior to standard non-surgical treatment.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 28, 2010

Completed
6.6 years until next milestone

Study Start

First participant enrolled

May 22, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2017

Completed
Last Updated

March 18, 2019

Status Verified

March 1, 2019

Enrollment Period

1 month

First QC Date

October 26, 2010

Last Update Submit

March 14, 2019

Conditions

Keywords

PeriodontitisDietary supplementation

Outcome Measures

Primary Outcomes (2)

  • Changes in clinical parameters

    The primary outcomes will be differences in the changes in the below parameters at 3-months post-supplementation between test and placebo groups: * % sites with marginal bleeding on probing (BOP) from baseline. * Probing pocket depth reductions (mm) from baseline (expressed as reductions in mean and also cumulative pocket depth).

    3 months

  • Changes in clinical parameters

    The primary outcomes will be differences in the changes in the parameters listed below at 6 months (3 months post supplementation + 3 months post treatment)in test and placebo groups % sites with marginal BOP from baseline. Probing pocket depth reductions (mm) from baseline (expressed as reductions in mean and also cumulative pocket depth).

    6 months

Secondary Outcomes (2)

  • Clinical and biochemical changes

    3 months

  • Clinical and biochemical changes

    6 months

Study Arms (2)

Supplementation with non-active

PLACEBO COMPARATOR

Subjects will be supplemented with placebo capsules (3 capsules am \& 3 capsules pm)

Dietary Supplement: Placebo non active capsules

Dietary supplementation with Juice plus+

ACTIVE COMPARATOR

Subjects will be supplemented with Juice plus+ capsules (3 capsules am \& 3 capsules pm)

Dietary Supplement: Juice plus+

Interventions

Juice plus+DIETARY_SUPPLEMENT

Subjects in active group will be supplemented with Juice plus+ capsules (3 in the morning and 3 in the evening, for 3 months)

Dietary supplementation with Juice plus+
Placebo non active capsulesDIETARY_SUPPLEMENT

Subjects will take non-active placebo capsules (3 in the morning and 3 in the evening, for 3 months)

Supplementation with non-active

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be aged 18 years old and over
  • have a minimum of 20 teeth
  • have chronic periodontitis
  • be capable of giving informed consent themselves

You may not qualify if:

  • Patients with aggressive disease
  • Patients with physical or mental disability
  • Pregnant women or those breastfeeding
  • Patients whose medical history may place them at risk of complications from periodontal therapy (e.g. warfarinised Volunteers)
  • Patients taking long term anti-microbial or anti-inflammatory drugs
  • Patients unable to swallow the study capsules, or take 6 of these capsules a day
  • Patients unable to provide informed consent
  • Taking dietary supplements (e.g. multivitamins, antioxidants, fish oils) or have taken them within 1-month of the study
  • Shows unwillingness, inability or lack of motivation to carry out the study procedures or is not prepared to give written consent or to refrain from using other oral hygiene products (mouthwashes, chewing gum, water piks etc.) or to undergo professional dental cleaning for the duration of the study (other than as part of this protocol)
  • Antibiotic or anti-inflammatory therapy currently or in previous two weeks
  • Current orthodontic treatment
  • Currently participating in another Dental Trial
  • Diabetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Wuerzburg

Würzburg, D-97070, Germany

Location

Academic Centre for Dentistry

Amsterdam, 1066 EA, Netherlands

Location

Birmingham Dental Hospital & School

Birmingham, West Midlands, B4 6NN, United Kingdom

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Iain L Chapple, BDS, PhD

    University of Birmingham

    PRINCIPAL INVESTIGATOR
  • Ulrich Schlagenhauf, PhD

    University of Wuerzburg

    PRINCIPAL INVESTIGATOR
  • Ubele Van der Velden, PhD

    Academic Centre for Dentistry in Amsterdam

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: longitudinal, randomised, block stratified (for smoking), double-blind, 2-arm interventional study
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor (PI to study)

Study Record Dates

First Submitted

October 26, 2010

First Posted

October 28, 2010

Study Start

May 22, 2017

Primary Completion

June 30, 2017

Study Completion

September 27, 2017

Last Updated

March 18, 2019

Record last verified: 2019-03

Locations